Cargando…

Hydralazine/unspecified calcium channel blocker: Lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777430/ http://dx.doi.org/10.1007/s40278-022-09122-z

Ejemplares similares

Unspecified loop diuretics/zirconium silicate: Lack of efficacy: case report
Publicado: (2021)

Management of anesthesia in unspecified extra-adrenal pheochromocytoma patient who used beta-blocker
por: Ozer, Ayse Belin, et al.
Publicado: (2014)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Immunosuppressants/unspecified steroids: COVID-19: 4 case reports
Publicado: (2021)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

A Case of Symptomatic Myocardial Bridge Treated with Calcium Channel Blocker
por: Nemat, Arash, et al.
Publicado: (2022)

Bowel ischemia in a baby with unspecified renovascular hypertension: a case report
por: Oda, Omar, et al.
Publicado: (2011)

Enoxaparin sodium/heparin/unspecified corticosteroid: Various toxcities: 2 case reports
Publicado: (2021)

A multifaceted approach to calcium channel blocker overdose: a case report and literature review
por: Burkes, Robert, et al.
Publicado: (2015)

Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports
por: Ames, Angharad, et al.
Publicado: (2019)

Glucocorticoids/immune globulin/unspecified corticosteroids: Systolic hypertension and sinus bradycardia: case report
Publicado: (2021)

Once was not enough: A case report of the concomitant intoxication of amlodipine (calcium channel blocker) and clonazepam (benzodiazepine)
por: Gautam, Swotantra, et al.
Publicado: (2022)

Linezolid/unspecified opioids interaction: Serotonin syndrome following drug-drug interaction: case report
Publicado: (2022)

Case Report: Anesthetic management for Cesarean section in a parturient with unspecified inherited bleeding disorder
por: Li, Li, et al.
Publicado: (2018)

Hydroxychloroquine/tacrolimus: Peripheral T-cell lymphoma unspecified and acute hypoxaemic respiratory failure: case report
Publicado: (2017)

Bevacizumab/temozolomide/unspecified steroids: Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis: case report
Publicado: (2020)

Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report
por: Hirakawa, Kyoko, et al.
Publicado: (2022)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Multi-organ dysfunction as a presentation of calcium channel blocker intoxication
por: Osman, Abdul-Fatawu, et al.
Publicado: (2022)

Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning
por: Saha, Biplab K., et al.
Publicado: (2020)

Hydralazine: Vasculitis, diffuse alveolar haemorrhage and pauci-immune crescentic glomerulonephritis : case report
Publicado: (2020)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017)

Gingival overgrowth as secondary effect of calcium channel blockers administration. A case report
por: Mironiuc-Cureu, M, et al.
Publicado: (2014)

Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review
por: Piscitani, Luca, et al.
Publicado: (2023)

Calcium Channel Blockers- Induced Iatrogenic Gingival Hyperplasia: Case Series
por: Priyadarshini, G. Agnes Golda, et al.
Publicado: (2023)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

Role of histopathology in the management of the gingival enlargement in a patient on antihypertensive therapy based on calcium channel blockers: a case report
por: Păunică, Stana, et al.
Publicado: (2022)

Convalescent-anti-sars-cov-2-plasma/rituximab/unspecified steroids: Fever and lymphodepletion: 2 case reports
Publicado: (2021)

Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
por: Dueñas-Gonzalez, Alfonso, et al.
Publicado: (2010)

Anti-TNF-α and hydralazine drug-induced lupus
por: Quaresma, Maria Victória, et al.
Publicado: (2015)

Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis
por: Holman, Sarah K., et al.
Publicado: (2017)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

Calcium Channel Blocker Overdose Treated with Calcium Resulting in Pancreatitis: A Case Report
por: Khan, Salman, et al.
Publicado: (2019)

Single-Pass Albumin Dialysis as Rescue Therapy for Pediatric Calcium Channel Blocker Overdose
por: Essink, Jenna, et al.
Publicado: (2022)

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report
por: Al-Abdouh, Ahmad, et al.
Publicado: (2020)

A metastatic intermediate trophoblastic tumor of unspecified subtype presenting as pneumothorax
por: Multani, Sukhpreet S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uiuf0vja7s646aba2kn26u1p0i